| PADT No relapse | PADT relapse | p value | EBRT No relapse | EBRT relapse | p value |
---|---|---|---|---|---|---|
Sample size | n = 15 | n = 15 |  | n = 15 | n = 15 |  |
Mean age | 74 (57-78) | 69 (60-78) | p = 0.09 NS | 65 (58-71) | 67 (52-77) | p = 0.26 NS |
Mean presenting PSA (ng/ml) | 23.9 (2.5-90.3) | 25 (5.2-251) | p = 0.36 NS | 15.5 (4.1-27.9) | 23.9 (3.6-107) | p = 0.25 NS |
Clinical stage |  |  | p = 0.06 NS |  |  | p = 0.89 NS |
T1 | 2 | 0 | Â | 2 | 4 | Â |
T2 | 9 | 7 | Â | 8 | 5 | Â |
T3 | 4 | 7 | Â | 5 | 6 | Â |
T4 | 0 | 1 | Â | 0 | 0 | Â |
Principle Gleason grade |  |  | p = 0.17 NS |  |  | p = 0.78 NS |
Gleason 3 | 7 | 4 | Â | 12 | 11 | Â |
Gleason 4 | 6 | 6 | Â | 2 | 4 | Â |
Gleason 5 | 2 | 5 | Â | 1 | 0 | Â |
Gleason grade sum |  |  | p = 0.25 NS |  |  | p = 0.93 NS |
6 | 3 | 1 | Â | 8 | 7 | Â |
7 | 7 | 4 | Â | 5 | 7 | Â |
8 | 0 | 5 | Â | 0 | 0 | Â |
9 | 4 | 4 | Â | 1 | 1 | Â |
10 | 1 | 1 | Â | 1 | 0 | Â |
Metastasis |  |  | p = 0.2 NS |  |  | p = 1.00 NS |
M0 | 13 | 9 | Â | 15 | 15 | Â |
M1 | 2 | 6 | Â | 0 | 0 | Â |